You are here

JT Pharmaceuticals, Inc.

Company Information
Address
300 W Coleman Blvd Ste 203
MOUNT PLEASANT, SC 29464-5641
United States



Information

DUNS: 079317899

# of Employees: 2


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Stroke Treatment by Chemically-induced Hypothermia

    Amount: $2,896,549.00

    ABSTRACTWhile acute stroke is a leading cause of human death and disability in the United Statesunfortunatelyclinical therapies for stroke are limited and unsatisfactoryThe overwhelming failures of st ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Stroke Treatment by Chemically-induced Hypothermia

    Amount: $1,500,000.00

    DESCRIPTION provided by applicant Stroke is a leading cause of human death and disability in the United States while clinical therapy for acute stroke is limited and unsatisfactoy The many failure ...

    STTRPhase II2015Department of Health and Human Services National Institutes of Health
  3. Development of a Neurotensin Fragment for Neuropathic Pain

    Amount: $1,247,235.00

    DESCRIPTION provided by applicant Neuropathic pain management is a major unmet clinical need Classically used medications opioids and non opioids NSAIDs have major side effects associated with t ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
  4. Engineered Neurotensin Fragments Targeting Neuropathic Pain

    Amount: $324,258.00

    DESCRIPTION (provided by applicant): Neuropathic pain management is a major unmet clinical need. Classically used medications, including opioids and non-opioids (primarily NSAIDs), have major side eff ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government